Literature DB >> 16997857

Depletion of MCP-1 increases development of herpetic stromal keratitis by innate immune modulation.

Bumseok Kim1, Pranita P Sarangi, Yunsang Lee, Shilpa Deshpande Kaistha, Sujin Lee, Barry T Rouse.   

Abstract

Chemokines are important chemoattractant inflammatory molecules, but their interdependent network in disease pathogenesis remains unclear. Studies in mouse models have shown that herpetic stromal keratitis (SK) is produced by the consequence of a tissue-destructive immunoinflammatory reaction involving herpes simplex virus type 1 (HSV) infection. Here we found that ocular HSV infection leads to increased expression of monocyte chemoattractant protein-1 (MCP-1), one of the major chemoattractants for immune cells that express CCR2, in the SK cornea. However, MCP-1 is unlikely to be a chemoattractant for infiltrating Gr-1(+), CD11b(+) cells in SK, as these cells are found to be CCR2 negative. Nevertheless, infection of MCP-1(-/-) mice resulted in more severe SK lesion severity compared with WT mice (P<0.01). We demonstrated that the loss of MCP-1 in the SK cornea caused a significant overexpression of macrophage inflammatory protein-2 (MIP-2) (P<0.01) on days 2 and 4 postinfection and increased infiltration of inflammatory cells (Gr-1-high and CD11b(+)) expressing CXCR2, a receptor for MIP-2, into the cornea. Subsequently, increased infiltration of inflammatory cells accelerated by MIP-2 overexpression might result in the high production of inflammatory molecules, including vascular endothelial growth factor (VEGF) and IL-1beta in SK, as well as CpG oligodeoxynucleotide (ODN)-implanted eyes of MCP-1(-/-) mice. These results indicate that MCP-1 in the SK cornea might regulate the expression of other chemokines, as well as the infiltration of inflammatory cells and control development of SK.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16997857     DOI: 10.1189/jlb.0406295

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  15 in total

1.  Controlling herpes simplex virus-induced ocular inflammatory lesions with the lipid-derived mediator resolvin E1.

Authors:  Naveen K Rajasagi; Pradeep B J Reddy; Amol Suryawanshi; Sachin Mulik; Per Gjorstrup; Barry T Rouse
Journal:  J Immunol       Date:  2010-12-27       Impact factor: 5.422

2.  Innate recognition network driving herpes simplex virus-induced corneal immunopathology: role of the toll pathway in early inflammatory events in stromal keratitis.

Authors:  Pranita P Sarangi; Bumseok Kim; Evelyn Kurt-Jones; Barry T Rouse
Journal:  J Virol       Date:  2007-08-08       Impact factor: 5.103

3.  A novel p40-independent function of IL-12p35 is required for progression and maintenance of herpes stromal keratitis.

Authors:  Gregory M Frank; Sherrie J Divito; Dawn M Maker; Min Xu; Robert L Hendricks
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-03-05       Impact factor: 4.799

4.  Galectin-1 reduces the severity of herpes simplex virus-induced ocular immunopathological lesions.

Authors:  Naveen K Rajasagi; Amol Suryawanshi; Sharvan Sehrawat; Pradeep B J Reddy; Sachin Mulik; Mitsuomi Hirashima; Barry T Rouse
Journal:  J Immunol       Date:  2012-03-30       Impact factor: 5.422

5.  IL-2/anti-IL-2 antibody complex treatment inhibits the development but not the progression of herpetic stromal keratitis.

Authors:  Subhash Gaddipati; Kathleen Estrada; Pushpa Rao; Andrew David Jerome; Susmit Suvas
Journal:  J Immunol       Date:  2014-11-19       Impact factor: 5.422

6.  VEGF blockade enables oncolytic cancer virotherapy in part by modulating intratumoral myeloid cells.

Authors:  Mark A Currier; Francis K Eshun; Allyson Sholl; Artur Chernoguz; Kelly Crawford; Senad Divanovic; Louis Boon; William F Goins; Jason S Frischer; Margaret H Collins; Jennifer L Leddon; William H Baird; Amy Haseley; Keri A Streby; Pin-Yi Wang; Brett W Hendrickson; Rolf A Brekken; Balveen Kaur; David Hildeman; Timothy P Cripe
Journal:  Mol Ther       Date:  2013-03-12       Impact factor: 11.454

7.  HSV keratitis: histopathologic predictors of corneal allograft complications.

Authors:  Roni M Shtein; Denise D Garcia; David C Musch; Victor M Elner
Journal:  Trans Am Ophthalmol Soc       Date:  2008

8.  Herpes simplex virus keratitis: histopathologic inflammation and corneal allograft rejection.

Authors:  Roni M Shtein; Denise D Garcia; David C Musch; Victor M Elner
Journal:  Ophthalmology       Date:  2009-07       Impact factor: 12.079

9.  Chemokine CXCL1/KC and its receptor CXCR2 are responsible for neutrophil chemotaxis in adenoviral keratitis.

Authors:  Ashish V Chintakuntlawar; James Chodosh
Journal:  J Interferon Cytokine Res       Date:  2009-10       Impact factor: 2.607

10.  Role of cysteine-rich 61 protein (CCN1) in macrophage-mediated oncolytic herpes simplex virus clearance.

Authors:  Amy Haseley Thorne; Walter H Meisen; Luke Russell; Ji Young Yoo; Chelsea M Bolyard; Justin D Lathia; Jeremy Rich; Vinay K Puduvalli; Hsiaoyin Mao; Jianhua Yu; Michael A Caligiuri; Susheela Tridandapani; Balveen Kaur
Journal:  Mol Ther       Date:  2014-06-04       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.